P53, as an important regulatory factor in the development of cancer, often played a role as a target protein in ccRCC (Huang et al., 2020; Patergnani et al., 2020; Chen et al., 2021a; Sekino et al., 2021a). Here, TP53 is linked to nonpapillary renal cell carcinoma.